343 related articles for article (PubMed ID: 18983534)
1. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo.
Taïeb A; Morice-Picard F; Jouary T; Ezzedine K; Cario-André M; Gauthier Y
Pigment Cell Melanoma Res; 2008 Dec; 21(6):646-52. PubMed ID: 18983534
[TBL] [Abstract][Full Text] [Related]
2. Experimental approaches to assess melanocytes mosaicism in segmental vitiligo.
Dellatorre G; Fava VM; Mira MT; Silva de Castro CC
An Bras Dermatol; 2023; 98(2):216-220. PubMed ID: 36529602
[TBL] [Abstract][Full Text] [Related]
3. The distribution pattern of segmental vitiligo: clues for somatic mosaicism.
van Geel N; Speeckaert R; Melsens E; Toelle SP; Speeckaert M; De Schepper S; Lambert J; Brochez L
Br J Dermatol; 2013 Jan; 168(1):56-64. PubMed ID: 22913564
[TBL] [Abstract][Full Text] [Related]
4. Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions.
Wu CS; Hu SC; Lan CC; Chen GS; Chuo WH; Yu HS
Kaohsiung J Med Sci; 2008 Apr; 24(4):180-9. PubMed ID: 18424354
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity in Segmental Vitiligo.
Speeckaert R; Lambert J; Bulat V; Belpaire A; Speeckaert M; van Geel N
Front Immunol; 2020; 11():568447. PubMed ID: 33193342
[TBL] [Abstract][Full Text] [Related]
6. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
Boniface K; Seneschal J; Picardo M; Taïeb A
Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients.
Ezzedine K; Diallo A; Léauté-Labrèze C; Mossalayi D; Gauthier Y; Bouchtnei S; Cario-André M; Seneschal J; Boralevi F; Jouary T; Taieb A
Br J Dermatol; 2011 Jul; 165(1):44-9. PubMed ID: 21410675
[TBL] [Abstract][Full Text] [Related]
8. Most individuals with either segmental or non-segmental vitiligo display evidence of bilateral cochlear dysfunction.
Anbar TS; El-Badry MM; McGrath JA; Abdel-Azim ES
Br J Dermatol; 2015 Feb; 172(2):406-11. PubMed ID: 25041189
[TBL] [Abstract][Full Text] [Related]
9. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
10. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
[TBL] [Abstract][Full Text] [Related]
11. The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.
Wang P; Li Y; Nie H; Zhang X; Shao Q; Hou X; Xu W; Hong W; Xu A
J Dermatol Sci; 2016 Oct; 84(1):40-49. PubMed ID: 27470284
[TBL] [Abstract][Full Text] [Related]
12. The genetics of generalized vitiligo.
Spritz RA
Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
[TBL] [Abstract][Full Text] [Related]
13. The genetics of generalized vitiligo and associated autoimmune diseases.
Spritz RA
J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in the Peripheral Blood of Patients with Segmental and Nonsegmental Vitiligo.
Willemsen M; Post NF; van Uden NOP; Narayan VS; Chielie S; Kemp EH; Bekkenk MW; Luiten RM
J Invest Dermatol; 2022 Mar; 142(3 Pt B):876-883.e3. PubMed ID: 34166674
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic and extrinsic pathomechanisms in vitiligo.
Taïeb A
Pigment Cell Res; 2000; 13 Suppl 8():41-7. PubMed ID: 11041356
[TBL] [Abstract][Full Text] [Related]
16. Vitiligo as an inflammatory skin disorder: a therapeutic perspective.
Taïeb A
Pigment Cell Melanoma Res; 2012 Jan; 25(1):9-13. PubMed ID: 22099450
[TBL] [Abstract][Full Text] [Related]
17. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS.
Schallreuter KU; Salem MA; Holtz S; Panske A
FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861
[TBL] [Abstract][Full Text] [Related]
18. Update on skin repigmentation therapies in vitiligo.
Falabella R; Barona MI
Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
[TBL] [Abstract][Full Text] [Related]
19. New insights into segmental vitiligo: A clinical and immunological comparison with nonsegmental vitiligo.
Xu X; Jiang M; Zhang C; Qiao Z; Liu W; Le Y; Wu J; Ma W; Xiang LF
Pigment Cell Melanoma Res; 2022 Mar; 35(2):220-228. PubMed ID: 34780118
[TBL] [Abstract][Full Text] [Related]
20. New insights in segmental vitiligo: case report and review of theories.
van Geel N; Mollet I; Brochez L; Dutré M; De Schepper S; Verhaeghe E; Lambert J; Speeckaert R
Br J Dermatol; 2012 Feb; 166(2):240-6. PubMed ID: 21936857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
